Menu
This opportunity is currently closed.
Sign up for Content alerts to stay informed when this or related funding opportunities are posted.
RESEARCH FUNDING
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
The Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports the development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases. Applications are open to researchers in the USA and worldwide. Applicants may apply for up to 275,000 USD for over 2 years.
Opportunity ID: PAR-23-119.
Full applications are due October 16, 2023.
Full application due:
October 16, 2023
October 16, 2023
